| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/31/1996 | EP0693928A1 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
| 01/31/1996 | EP0693927A1 Method for treatment of menopausal and premenstrual symptoms |
| 01/31/1996 | EP0693926A1 Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
| 01/31/1996 | EP0693922A1 Pharmaceutical composition containing lipophilic drugs |
| 01/31/1996 | EP0693921A1 Anti-oxidant alkylaryl polyether alcohol polymers |
| 01/31/1996 | EP0693919A1 Oral compositions for treating plaque and gingivitis containing a noncationic antibacterial agent and a bicarbonate salt |
| 01/31/1996 | EP0693874A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 01/31/1996 | EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 01/31/1996 | EP0606197B1 Use of aromatic benzoates as personal deodorants |
| 01/31/1996 | EP0593615B1 Aromatic compounds, compositions containing them and their use in therapy |
| 01/31/1996 | EP0593557B1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/31/1996 | EP0456817B1 Process for the preparation of 2-amino-9-(2,3,5-tri-0-benzyl-beta-d-arabinofuranosyl)adenine and novel intermediates |
| 01/31/1996 | CN1115982A Pharmacologically active pyridine derivatives and processes for the preparation thereof |
| 01/31/1996 | CN1115981A New chemopreventive compounds and a preparation method and use thereof |
| 01/31/1996 | CN1115980A Dehydrogenation process |
| 01/31/1996 | CN1115979A New crystalline form of vitamin D analogue |
| 01/31/1996 | CN1115963A Cerebral metabolism activator containing glucose ester derivative |
| 01/31/1996 | CN1115768A Particles of cross-linked anion exchange agent and production of same |
| 01/31/1996 | CN1115761A Derivative, preparation and medical application of quinoline and imidazole |
| 01/31/1996 | CN1115759A Tricyclic carboxylate |
| 01/31/1996 | CN1115756A Method for preparing pharmaceutically active CNS compounds |
| 01/31/1996 | CN1115671A Active component of cordyceps sinensis and its separation method |
| 01/31/1996 | CN1115662A Drug for acne and its prepn |
| 01/31/1996 | CN1115643A Anticarcinogen |
| 01/31/1996 | CN1115642A Analgesic 'Kangnaipan' |
| 01/31/1996 | CN1115641A Prepn of cyclopropyloxacini injecta |
| 01/31/1996 | CN1115640A Application of 3-substituted aryl oxidized indole compounds |
| 01/31/1996 | CN1115639A Vaginal suppository of 0.25 mg compound stilbestrol |
| 01/31/1996 | CN1115600A Compositions containing 13-alkyl-23-imino derivative of LL-28249 compounds and their use |
| 01/31/1996 | CA2154910A1 Method for the racemisation of enantiomers of .alpha.-lipoic acid |
| 01/30/1996 | US5488151 {(7S)-7-[(2R)-2-(3-chlorophenyl)-2-hydroxyethylamino)-2-hydroxyethylamino]5,} acetic acid and its pharmaceutically acceptable salts |
| 01/30/1996 | US5488150 Antidiabetic agents or hypoglycemic agents |
| 01/30/1996 | US5488145 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
| 01/30/1996 | US5488135 Bis(phenyl)ethane derivatives |
| 01/30/1996 | US5488120 1α-hydroxy vitamin D4 and novel intermediates and analogues |
| 01/30/1996 | US5488116 Total synthesis of taxol and analogues thereof |
| 01/30/1996 | US5488111 8-sulfo-3-quinoline carboxylic acid compounds |
| 01/30/1996 | US5488110 Highly water soluble bis-naphthalimides useful as anticancer agents |
| 01/30/1996 | US5488075 Injectable fluid of maleic anhydride-styrene copolymer in dimethyl sulfoxide |
| 01/30/1996 | US5488069 Antiinflammatory agents for eyes |
| 01/30/1996 | US5488068 Aminobiphenyl-4-ol anti-atherosclerotic compounds and method |
| 01/30/1996 | US5488066 Alkylaminoalkyl-terminated sulfide/sulfonyl-containing cycloalkyl-alanine amino-diol compounds for treatment of hypertension |
| 01/30/1996 | US5488063 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds |
| 01/30/1996 | US5488062 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 01/30/1996 | US5488061 Antiinflammatory, anticaracinogenic agents; bactericides, fungicides |
| 01/30/1996 | US5488059 N-cyano-n'-/1,1-dimethylpropyl/-n?-3-pyridinylguanidine |
| 01/30/1996 | US5488058 Urogenital disorders or osteoporosis |
| 01/30/1996 | US5488057 2-oxindole compounds which have useful tyrosine kinase activity |
| 01/30/1996 | US5488056 Method for treating anxiety |
| 01/30/1996 | US5488055 Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof |
| 01/30/1996 | US5488054 Treatment of restenosis |
| 01/30/1996 | US5488053 Tetrahydro-pyrido-indole |
| 01/30/1996 | US5488051 Bactericides, fungicides, algicides and antiprotozoa agents |
| 01/30/1996 | US5488050 Methods and products for treating presbyopia |
| 01/30/1996 | US5488049 Method of treating learning and memory disorders using benzothiadiazide derivatives as nootropic agents |
| 01/30/1996 | US5488048 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ace |
| 01/30/1996 | US5488044 Method of treating metabolic bone disease with (E)-20(22)-dehydrovitamin D compounds |
| 01/30/1996 | US5488042 Method for protection against genotoxic mutagenesis |
| 01/30/1996 | US5488041 Method of promoting bone repair using tiludronic disodium salt |
| 01/30/1996 | US5488040 Stimulating the production of cytokines for hematopoietic and immunology |
| 01/30/1996 | US5487916 Method for coating particles in a spray-drying plant |
| 01/30/1996 | US5487900 Stabilized vitamin D preparation |
| 01/30/1996 | US5487897 Thermoplastic polymer, in vivo coagulation, drug delivery, wound healing, tissue regeneration |
| 01/30/1996 | US5487893 Antiviral use of a 2,6-di-t-butylphenol compound substituted in 4 position against herpes viruses and papillomaviruses |
| 01/30/1996 | US5487888 Iron-binding polymers for oral administration |
| 01/30/1996 | US5487884 Photoprotection compositions comprising chelating agents |
| 01/30/1996 | CA2154907A1 Use of eliprodil and enantiomers thereof for the preparation of medicines useful for preventing peripheral neuropathies induced by anticancer agents |
| 01/30/1996 | CA2154906A1 Use of ifenprodil and diastereoisomers thereof for the preparation of medicines useful in the treatment of pheripheral neuropathies and central neurodegenerative diseases |
| 01/30/1996 | CA2055905C Pharmaceutical composition comprising calcium polycarbophil |
| 01/30/1996 | CA2031572C Non-alcoholic delivery system for orally ingestible active ingredients |
| 01/30/1996 | CA2003856C Therapeutic agent for renal disorders |
| 01/30/1996 | CA2001004C Antiemesis ergoline derivatives |
| 01/30/1996 | CA1338018C 6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones and 6- thiophenoxymethyl-4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, processes for the preparation of these compounds, their use as pharmaceuticals, pharmaceutical preparations and novel phenols and thiophenols |
| 01/30/1996 | CA1338017C Derivatives of physiologically active substance ml-236b and process for production thereof |
| 01/30/1996 | CA1338013C Substituted pyrrole, pyrazole and triazole angiotensin ii antagonists |
| 01/30/1996 | CA1338012C Pharmaceutically active amines |
| 01/30/1996 | CA1338009C Prolonged activity nicotine patch |
| 01/30/1996 | CA1338008C Transdermal flux enhancing compositions |
| 01/28/1996 | CA2154745A1 Treatment of impotence |
| 01/28/1996 | CA2154626A1 Red-shifted tris-aryl-s-triazines and compositions stabilized therewith |
| 01/28/1996 | CA2154624A1 Azaaliphatically bridged quinoxaline-2,3-diones |
| 01/26/1996 | WO1996001625A1 Multiple unit tableted dosage form containing proton pump inhibitor |
| 01/26/1996 | EP0711175A4 Topical compositions for re-epitheliazation of persistent epithelial defects |
| 01/26/1996 | CA2170995A1 Multiple unit tableted dosage form containing proton pump inhibitor |
| 01/25/1996 | WO1996001901A1 Streptogramines and method for preparing same by mutasynthesis |
| 01/25/1996 | WO1996001898A1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/25/1996 | WO1996001893A1 Recombinant kat enzyme and process for its preparation |
| 01/25/1996 | WO1996001849A1 Fractionated polydisperse compositions |
| 01/25/1996 | WO1996001833A1 Therapeutic compounds |
| 01/25/1996 | WO1996001829A1 PYRIDO[3,2,1-i,j][3,1]BENZOXAZINE DERIVATIVES |
| 01/25/1996 | WO1996001827A1 Tetracyclic derivatives and their use as antitumour agents |
| 01/25/1996 | WO1996001825A1 Heterobicyclic derivatives |
| 01/25/1996 | WO1996001824A1 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product |
| 01/25/1996 | WO1996001822A1 Anti-helicobacter acyl derivatives of azolones |
| 01/25/1996 | WO1996001821A1 Anti-helicobacter heterocyclic derivatives of azolones |
| 01/25/1996 | WO1996001820A1 Anti-helicobacter urea and thiourea derivatives of azolones |
| 01/25/1996 | WO1996001819A1 Heterocyclic tachykinin receptor antagonists |
| 01/25/1996 | WO1996001818A1 Sulfonamide derivatives of azolones anti-helicobacter agents |
| 01/25/1996 | WO1996001817A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 01/25/1996 | WO1996001815A1 METHOD FOR PREPARING 4-ACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1,7β,10β-TRIHYDROXY-9-OXO-TAX-11-EN-13α-YL(2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE TRIHYDRATE |